These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6104500)

  • 21. Labetalol possesses beta-adrenoceptor agonist action on the rat isolated uterus.
    Carey B; Whalley ET
    J Pharm Pharmacol; 1979 Nov; 31(11):791-2. PubMed ID: 41918
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of digoxin on isolated human peripheral arteries and veins.
    Mikkelsen E; Andersson KE; Pedersen OL
    Acta Pharmacol Toxicol (Copenh); 1979 Oct; 45(4):249-56. PubMed ID: 43072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of labetalol and YM-09538 on neuronal uptake of (3H)norepinephrine in the rat vas deferens.
    Cohen ML; Hynes LM
    Clin Exp Hypertens A; 1983; 5(4):563-75. PubMed ID: 6133660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of labetalol (AH 5158) on adrenergic transmission in the cat spleen.
    Blakeley AG; Summers RJ
    Br J Pharmacol; 1977 Apr; 59(4):643-50. PubMed ID: 15698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dicentrine, a natural vascular alpha 1-adrenoceptor antagonist, isolated from Lindera megaphylla.
    Teng CM; Yu SM; Ko FN; Chen CC; Huang YL; Huang TF
    Br J Pharmacol; 1991 Nov; 104(3):651-6. PubMed ID: 1686739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific enhancement of norepinephrine-induced contraction in rat veins after beta adrenergic antagonists.
    Cohen ML; Wiley KS
    J Pharmacol Exp Ther; 1977 May; 201(2):406-16. PubMed ID: 16122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927.
    Sybertz EJ; Sabin CS; Pula KK; Vliet GV; Glennon J; Gold EH; Baum T
    J Pharmacol Exp Ther; 1981 Aug; 218(2):435-43. PubMed ID: 6114171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta1-Adrenoceptor-mediated relaxation by norepinephrine in dog hepatic arteries.
    Shiraishi S; Okamura T; Toda N
    Jpn J Pharmacol; 1997 Jan; 73(1):101-3. PubMed ID: 9032140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-adrenoceptor blockade by labetalol during long-term dosing.
    Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F
    Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of age on the responses of human isolated arteries and veins to noradrenaline.
    Stevens MJ; Lipe S; Moulds RF
    Br J Clin Pharmacol; 1982 Nov; 14(5):750-2. PubMed ID: 7138759
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacology of labetalol in experimental animals.
    Baum T; Sybertz EJ
    Am J Med; 1983 Oct; 75(4A):15-23. PubMed ID: 6314811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of beta-mimetics on the contractile reactivity of isolated human placental blood vessels].
    Urban J; Krygicz J
    Ginekol Pol; 1983 Mar; 54(3):151-3. PubMed ID: 6884804
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastric fundus using the beta(3)-adrenoceptor antagonist bupranolol.
    Horinouchi T; Koike K
    Pharmacology; 1999 Dec; 59(6):290-7. PubMed ID: 10575323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular hypotensive action of labetalol.
    Leopold IH; Murray DL
    Am J Ophthalmol; 1979 Sep; 88(3 Pt 1):427-31. PubMed ID: 484671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A response to isoprenaline unrelated to alpha- and beta-adrenoceptor agonism.
    Bond RA; Clarke DE
    Br J Pharmacol; 1987 Jul; 91(3):683-6. PubMed ID: 2886175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-substituted 2-amino-1-(2-thienyl)ethanols as beta-adrenergic blocking agents.
    Corral C; Darias V; Fernández-Tomé MP; Madroñero R; Del Río J
    J Med Chem; 1973 Aug; 16(8):882-5. PubMed ID: 4147684
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific adrenergic responses of smooth muscles in the vascular wall of guinea pig pulmonary arteries during ovalbumin sensitization.
    Kapilevich LV; Nosarev AV; Djakova EJ; Ogorodova LM; Zaitseva TN; Davletjarova KV; Kovalev IV; Baskakov MB; Sazonov AE; Medvedev MA
    Bull Exp Biol Med; 2008 Jun; 145(6):673-5. PubMed ID: 19110547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the beta-receptor antagonists propranolol, oxprenolol and labetalol on human vascular smooth-muscle contraction.
    Moulds RF; Jauernig RA; Hobson JD; Shaw J
    Clin Sci Mol Med; 1978 Sep; 55(3):235-40. PubMed ID: 29741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of noradrenaline by labetalol in the rat anococcygeus muscle.
    Doggrell SA; Paton DM
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):103-8. PubMed ID: 732886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.